Back

Cholesterol efflux: what do we know, where are we heading?

26 August 2022 (13:15 - 13:30)
Organised by:
Congress Presentation Part of: Cholesterol efflux explained: a potential role in clinical outcomes Acute Coronary Syndromes Open Access ESC Congress 2022

About the speaker

Photo
Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Opening and welcome.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
The management of our patients post-AMI: can we do more?
Professor U. Zeymer (Ludwigshafen, DE)
Video
Presentation thumbnail
Discussion.
Professor K. Ray (London, GB) Professor U. Zeymer (Ludwigshafen, DE) Professor A. Catapano (Milan, IT)
Video
Presentation thumbnail
Discussion.
Professor U. Zeymer (Ludwigshafen, DE) Professor K. Ray (London, GB) Professor A. Catapano (Milan, IT)
Video
Presentation thumbnail
Summary and close.
Professor K. Ray (London, GB)
Video

Access the full session

Session thumbnail
Cholesterol efflux explained: a potential role in clinical outcomes
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients
26 August 2023
thumbnail
Congress Session
Innovating the clinical management of LDL-c: exploring CETP as therapeutic target
30 August 2024
thumbnail
Congress Presentation
Impaired high-density lipoprotein-associated cholesterol efflux capacity predicts coronary rapid plaque progression
1 September 2024
thumbnail
Congress Presentation
Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources